Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Germany is the most important venue for patent litigation in Europe

"I believe there is a fundamental flaw, and that is why the price is where it is at."

That's my fear, too.

Since years we all here assume to be the smartest ones, when it comes to the chances and possibilities of PTSC, but in the meantime, the biggest investor in PTSC sold tens of millions of shares no matter, how the shareprice decreased (ok, he got the shares for free, so even a Cent is a gain for him), the shareprice went down and the number of shareholders is smaller than two or three years ago.

By looking in the world, it's no doubt to me, that we are the only ones, who believe in PTSC's bright future - and the question becomes stronger and stronger to me, if there is one in a reasonable time...

I remember RG saying at his presentation in February (someone here posted the link to the video), he is speaking about the future in three to seven years. Well, given this timeframe I don't think any serious investors is under pressure purchasing PTSC NOW.

To come back to the german decision: IF this was such an important (= positive) decision, some smart guys would have started to purchase some stock - but nothing happened in the last five weeks, besides we broke through the 10-Cent-mark and got one-digit prices...not really a positive sign.

GLTY

Share
New Message
Please login to post a reply